Delivery Order SPE2DB20D2104-SPE2DB25FMVXM
Award Date 7/21/25
Potential Completion Date 8/11/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,271.65 by the Defense Logistics Agency on July 22, 2025, for the supply of ProQuad vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at one thousand five hundred fifty-seven dollars and fifty-nine cents ($1,557.59) by the Defense Logistics Agency (DLA) to supply ProQuad vaccine vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies to be delivered by December 28, 2023. Issued against an indefinite-delivery contract held by Amerisourcebergen with DLA for pharmaceutical and...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of ProQuad vials valued at $13,234.64 with a completion date of August 11, 2025. This non-competitive delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $16.87K delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 15, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, which aligns with AmerisourceBergen's established role as a critical federal pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a $6,405.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials with an ultimate completion date of August 12, 2025. This non-set-aside contract was competitively awarded and reflects the agency's ongoing pharmaceutical procurement through its Medical Supply Chain. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary distribution...
- The Defense Logistics Agency awarded a $1,670.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 15, 2025. This is a non-set-aside, competitively awarded contract executed on July 25, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at one thousand five hundred fifty-seven dollars and fifty-nine cents ($1,557.59) by the Defense Logistics Agency (DLA) to supply PROQUAD vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by December 8, 2023. No set-aside designation was applied to this award made against an unmentioned indefinite-delivery contract vehicle. As a...
- The Defense Logistics Agency awarded a delivery order valued at $5,372.90 to AmerisourceBergen Drug Corp for ProQuad vials on July 24, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $3,341.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitive award, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. ProQuad is a combination vaccine protecting...
- Amerisourcebergen Drug Corporation, operating as a division of its parent company Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $1,558 by the Defense Logistics Agency Troop Support Medical (DLA) to provide PROQUAD vaccine vials. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a start date of August 28, 2023 through completion by September 19, 2023. No subcontractors or set aside designations...